Skip to main content

Table 1 Baseline characteristics

From: Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

Characteristic

HIV + (n = 150)

HIV- (n = 155)

P-value

Age

34.2 ± 8.3

27.2 ± 9.5

<0.001

Gender (M:F, %)

83:17

58:42

<0.001

BMI (kg/m2)

18.1 ± 2.8

17.9 ± 3.6

0.48

Haemoglobin (g/dL)

10.0 ± 2.2

11.1 ± 1.8

<0.001

Erythrocyte sedimentation rate (mm/hr)

49.4 ± 23.6

43.7 ± 21.4

0.03

Absolute lymphocyte count (/mm3)

2071 ± 1010

2435 ± 938

0.001

CD4 count (/mm3)

194 ± 167

593 ± 232

<0.001

Albumin (g/dL)

3.5 ± 0.7

4.2 ± 0.6

<0.001

Bilirubin (mg/dL)

0.65 ± 0.24

0.67 ± 0.16

0.48

Alanine aminotransferase (IU/L)

53.7 ± 42.5

39.2 ± 21.9

<0.001

Aspartate aminotransferase (IU/L)

48.2 ± 70.3

32.7 ± 21.0

<0.01

Uric acid (units)

5.7 ± 2.7

5.1 ± 1.5

<0.01

Viral load (log copies/mL)

5.23 (4.74-5.76)

 
  1. Mean +/− standard deviation except median (inter-quartile range) in viral load.